GEMC-511687796642731
Awarded to J B PHARMA
₹28,200
Products
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| CLONAZEPAM 0.25MG TABLET | MANKIND / CLONAFIT 0.25 MD TAB | 30049089 | 30,000 tablet(s) | 0.94 | 28,200 |
Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹28,200Qualified 442 A 11 ROXY HOTEL LANE BADAMBADI CUTTACK ODISHA 753009 | CUTTACK | ODISHA | 753009 | L1 | Qualified |
Tender Value
₹28,200
EMD Value
Exempted
Closing Date
4 Dec 2025, 9:00 amClosed
CLONAZEPAM 0.25MG TABLET
8562364
GEM/2025/B/6868188
Single Packet Bid
CLONAZEPAM 0.25MG TABLET
GeM Contract
1 days
759145, PURCHASE DEPARTMENT, NALCO SMELTER PLANT, NALCO NAGAR Quanti ty Delivery to start after __________ Delivery to be completed by
Total value wise evaluation
PRODUCT_CUSTOM
Awarded to J B PHARMA
₹28,200
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| CLONAZEPAM 0.25MG TABLET | MANKIND / CLONAFIT 0.25 MD TAB | 30049089 | 30,000 tablet(s) | 0.94 | 28,200 |
3 documents required · 3 mandatory
Exempted
16 Jan 2026
13 Nov 2025
4 Dec 2025
CLONAZEPAM 0.25MG TABLET | Brand:MANKIND | Model:CLONAFIT 0.25 MD TAB | HSN:30049089 | Qty:30,000 tablet(s) | UnitPrice:0.94 | Amount:28,200
contract_GEMC-511687796642731.pdf
GEM_CONTRACT • 0.09 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8562364.pdf
GEM_BID
nit_technical_specification_medicine_2025-11-08-09-37-10_6633a949be06156f20dad77fa1100dcb.pdf
SPECIFICATION
ATC_59e25e0b-7aed-4af5-af4c1762575285191_sandipsahoo.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .